Tri-Heal (TB-500 + BPC-157 + KPV) dosage chart

Reconstitution steps

1. 1Draw 3.0 mL bacteriostatic water with a sterile syringe.
2. 2Inject slowly down the vial wall; avoid foaming or direct stream onto the lyophilized cake.
3. 3Gently swirl or roll until fully dissolved (do not shake vigorously).
4. 4Label with date and concentration (15 mg/mL); refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Dosing Cycle & Timing

This protocol runs on a 5 days on / 2 days off cycle.

• Cycle: 5 days on, 2 days off — dose Monday through Friday and rest on the weekend.
• 5 dosing days per week; the 2 off days help limit receptor desensitisation and give injection sites time to recover.
• Keep the dose time consistent on dosing days.
• If a weekday dose is missed, take it the same day if possible — do not dose on an off day to catch up.
• Weekly totals in the supplies and shopping lists are calculated on 5 dosing days, not 7.

Protocol Overview

Concise summary of the once-daily regimen.

• Goal: Support tissue repair, regeneration, and inflammation modulation through synergistic peptide action.
• Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
• Dose Range: 500–4000 mcg daily with gradual titration.
• Reconstitution: 3.0 mL per 45 mg vial (15 mg/mL) for accurate unit measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach.

• Start: 500 mcg daily; increase by 500 mcg every 2 weeks as tolerated.
• Target: 1500–2000 mcg daily by Weeks 5–8 (standard); up to 3000–4000 mcg for extended protocols.
• Frequency: Once per day (subcutaneous).
• Cycle Length: 8–12 weeks; optional extension to 16 weeks.
• Timing: Any consistent time; rotate injection sites systematically.

Storage Instructions

Proper storage preserves peptide quality and potency.

• Lyophilized: Store at −20 °C (−4 °F) or colder (ideally −80 °C / −112 °F for long-term) in dry, dark conditions.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 4 weeks; prepare aliquots if needed and avoid freeze–thaw cycles.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes for each injection; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and prevent lipohypertrophy.
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose, site rotation, and any observations to maintain consistency.
• For doses under 10 units, use 30-unit or 50-unit insulin syringes for improved accuracy.

How This Works

Tri-Heal combines three peptides with complementary mechanisms targeting multiple aspects of tissue injury repair:

TB-500 (Thymosin β4): Acts as a natural repair factor, inhibiting inflammation and apoptosis while promoting angiogenesis, cell migration, and matrix remodeling. This 43-amino-acid peptide has been shown to accelerate dermal healing in both preclinical models and clinical applications.

BPC-157 (Body Protection Compound): Enhances healing via VEGFR2/Akt-eNOS activation, increasing nitric oxide production and angiogenesis while stimulating fibroblast activity. This 15-amino-acid gastric peptide accelerates tendon, muscle, and gut repair.

KPV (Lys-Pro-Val): Provides anti-inflammatory effects by reducing NF-κB activation and attenuating pro-inflammatory cytokine signaling in epithelial and immune cells. This α-MSH-derived tripeptide complements the regenerative actions of TB-500 and BPC-157.

The combination thus addresses wound repair, angiogenesis, and inflammation simultaneously through distinct but synergistic pathways.

Potential Benefits & Side Effects

Observations from preclinical and clinical literature on the individual components.

Note: Human clinical data on this specific combination is limited; observations are extrapolated from studies of individual components.

• TB-500: Promotes cell proliferation, angiogenesis, and accelerated tissue repair; inhibits apoptosis and inflammation in healing tissues.
• BPC-157: Accelerates musculoskeletal healing including tendon and muscle repair; stimulates endothelial regeneration and fibroblast activity.
• KPV: Reduces inflammatory cytokine release; demonstrates efficacy in models of epithelial inflammation.
• General tolerability: Individual peptides are generally well tolerated in preclinical studies; occasional mild injection-site reactions (redness, transient discomfort) may occur with subcutaneous administration.

Lifestyle Factors

Complementary strategies for optimal recovery outcomes.

• Pair with adequate protein intake (1.6–2.2 g/kg body weight) to support tissue regeneration.
• Maintain appropriate activity levels; avoid overloading healing tissues while promoting controlled movement.
• Prioritize sleep (7–9 hours) to maximize endogenous repair processes.
• Manage stress through appropriate techniques, as chronic stress impairs healing.
• Stay well-hydrated and maintain balanced micronutrient intake (vitamin C, zinc, collagen precursors).

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

• Clean the vial stopper and skin with alcohol; allow to dry completely before proceeding.
• Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
• Do not aspirate for subcutaneous injections; inject slowly and steadily.
• Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy and local irritation.
• Dispose of used syringes in an approved sharps container; never recap or reuse needles.

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. For research use only. Not for human consumption.

Tri-Heal (TB-500 + BPC-157 + KPV) dosage FAQs